Literature DB >> 17266792

Kinetics of cell death of frozen-thawed human embryonic stem cell colonies is reversibly slowed down by exposure to low temperature.

B C Heng1, C P Ye, H Liu, W S Toh, A J Rufaihah, T Cao.   

Abstract

A major challenge in the widespread application of hES (human embryonic stem) cells in clinical therapy and basic scientific research is the development of efficient cryopreservation protocols. Conventional slow-cooling protocols utilizing standard cryoprotectant concentrations i.e. 10% (v/v) DMSO, yield extremely low survival rates of less than 5% as reported by previous studies. This study characterized cell death in frozen-thawed hES colonies that were cryopreserved under standard conditions. Surprisingly, our results showed that immediately after post-thaw washing, the overwhelming majority of hES cells were viable (approximately 98%), as assessed by the trypan blue exclusion test. However, when the freshly thawed hES colonies were placed in a 37 degrees C incubator, there was a gradual reduction in cell viability over time. The kinetics of cell death was drastically slowed down by keeping the freshly thawed hES colonies at 4 degrees C, with more than 90% of cells remaining viable after 90 min of incubation at 4 degrees C. This effect was reversible upon re-exposing the cells to physiological temperatures. The vast majority of low temperature-exposed hES colonies gradually underwent cell death upon incubation for a further 90 min at 37 degrees C. Hence, our observations would strongly suggest involvement of a self-induced apoptotic mechanism, as opposed to cellular necrosis arising from cryoinjury.

Entities:  

Mesh:

Year:  2006        PMID: 17266792     DOI: 10.1017/S0967199406003893

Source DB:  PubMed          Journal:  Zygote        ISSN: 0967-1994            Impact factor:   1.442


  6 in total

1.  Rationally optimized cryopreservation of multiple mouse embryonic stem cell lines: I--Comparative fundamental cryobiology of multiple mouse embryonic stem cell lines and the implications for embryonic stem cell cryopreservation protocols.

Authors:  Corinna M Kashuba; James D Benson; John K Critser
Journal:  Cryobiology       Date:  2013-12-30       Impact factor: 2.487

2.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

3.  An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells.

Authors:  Frida Holm; Susanne Ström; José Inzunza; Duncan Baker; Anne-Marie Strömberg; Björn Rozell; Anis Feki; Rosita Bergström; Outi Hovatta
Journal:  Hum Reprod       Date:  2010-03-05       Impact factor: 6.918

4.  Cryopreservation effects on Wharton's Jelly Stem Cells proteome.

Authors:  F Di Giuseppe; L Pierdomenico; E Eleuterio; M Sulpizio; P Lanuti; A Riviello; G Bologna; M Gesi; C Di Ilio; S Miscia; M Marchisio; S Angelucci
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

Review 5.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

Review 6.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.